In this Section |
161334 Utilization of genetic counselors in navigating new reproductive technologiesSunday, November 4, 2007
Women's pregnancies are now associated with a constant notion of risk, with genetic testing and reproductive technologies becoming a routine part of conception and prenatal care. It is commonly accepted that the medical community will need genetic services, and specifically genetic counselors, to translate and make sense of what is often complicated information about risk and susceptibility of genetic conditions. Although genetic counselors have become a central part of genetic services, there has been little research done on their exact role within the current purview of medicine, specifically how they can be better utilized in navigating the complex field of reproductive technologies. A study utilizing 39 in-depth, semi-structured interviews with genetic counselors, clinical geneticists, obstetricians, and key informants in the genetics field was conducted in order to better understand how genetic counselors are utilized in helping people make decisions about reproductive technologies. Respondents interviewed for this study underscored the public's lack of understanding or awareness of genetics, and the ability of genetic counselors to provide an important service in educating patients and physicians about the complexity of genetic testing and new reproductive technologies. Genetic counselors have the scientific expertise in genetics as well as the communication skills to help patients understand the terminology of genetic testing and technology and guide them in making an informed decision in a non-directive manner. This study demonstrated the importance utilizing genetic counselors within reproductive health and ensuring that they are properly integrated into patient care.
Learning Objectives: Keywords: New Technology, Genetics
Presenting author's disclosure statement:
Any relevant financial relationships? No I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.
See more of: Issues in Maternal Health: Global
See more of: Population, Family Planning, and Reproductive Health |